Literature DB >> 12705857

Analysis of clonotype distribution and persistence for an influenza virus-specific CD8+ T cell response.

Stephen J Turner1, Gabriela Diaz, Richard Cross, Peter C Doherty.   

Abstract

The spectrum of TCR V beta usage is compared for primary and recall CD8(+)D(b)PA(224)(+) T cell responses in mice with influenza pneumonia. Single-cell RT-PCR established that the same clonotypes were present in the lymphoid tissue and in the virus-infected lung. Longitudinal analysis indicated that the memory TCR repertoire reflects the primary response, with no decrease in diversity prior to (or after) secondary challenge. The re-engagement of memory T cells looked to be stochastic in this localized, transient infection. Analysis of clonotypes from the blood, spleen, regional lymph nodes, bone marrow, lung, and liver over a 200 day interval showed no evidence of selective localization or loss. The long-term distribution of memory T cells seemed to be essentially random.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12705857     DOI: 10.1016/s1074-7613(03)00087-6

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  55 in total

1.  Conserved T cell receptor usage in primary and recall responses to an immunodominant influenza virus nucleoprotein epitope.

Authors:  Katherine Kedzierska; Stephen J Turner; Peter C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-22       Impact factor: 11.205

Review 2.  Nature and nurture: T-cell receptor-dependent and T-cell receptor-independent differentiation cues in the selection of the memory T-cell pool.

Authors:  Chulwoo Kim; Matthew A Williams
Journal:  Immunology       Date:  2010-08-25       Impact factor: 7.397

Review 3.  Mapping the life histories of T cells.

Authors:  Ton N M Schumacher; Carmen Gerlach; Jeroen W J van Heijst
Journal:  Nat Rev Immunol       Date:  2010-08-06       Impact factor: 53.106

4.  Primary CTL response magnitude in mice is determined by the extent of naive T cell recruitment and subsequent clonal expansion.

Authors:  Nicole L La Gruta; William T Rothwell; Tania Cukalac; Natasha G Swan; Sophie A Valkenburg; Katherine Kedzierska; Paul G Thomas; Peter C Doherty; Stephen J Turner
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

Review 5.  The persistence of T cell memory.

Authors:  Mark A Daniels; Emma Teixeiro
Journal:  Cell Mol Life Sci       Date:  2010-04-04       Impact factor: 9.261

6.  TCRβ repertoire of CD4+ and CD8+ T cells is distinct in richness, distribution, and CDR3 amino acid composition.

Authors:  Hoi Ming Li; Toyoko Hiroi; Yongqing Zhang; Alvin Shi; Guobing Chen; Supriyo De; E Jeffrey Metter; William H Wood; Alexei Sharov; Joshua D Milner; Kevin G Becker; Ming Zhan; Nan-ping Weng
Journal:  J Leukoc Biol       Date:  2015-09-22       Impact factor: 4.962

7.  Early establishment of diverse T cell receptor profiles for influenza-specific CD8(+)CD62L(hi) memory T cells.

Authors:  Katherine Kedzierska; Vanessa Venturi; Kenneth Field; Miles P Davenport; Stephen J Turner; Peter C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

8.  Rapid recruitment of virus-specific CD8 T cells restructures immunodominance during protective secondary responses.

Authors:  Anne E Tebo; Michael J Fuller; Dalia E Gaddis; Kyoko Kojima; Kunal Rehani; Allan J Zajac
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

9.  Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity.

Authors:  Markus Cornberg; Alex T Chen; Lee A Wilkinson; Michael A Brehm; Sung-Kwon Kim; Claudia Calcagno; Dario Ghersi; Roberto Puzone; Franco Celada; Raymond M Welsh; Liisa K Selin
Journal:  J Clin Invest       Date:  2006-04-13       Impact factor: 14.808

Review 10.  The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research.

Authors:  Jeffrey L Curtis; Christine M Freeman; James C Hogg
Journal:  Proc Am Thorac Soc       Date:  2007-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.